Inner Mongolia Furui Med Sci
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules… Read more
Inner Mongolia Furui Med Sci (300049) - Total Liabilities
Latest total liabilities as of September 2025: CN¥865.30 Million CNY
Based on the latest financial reports, Inner Mongolia Furui Med Sci (300049) has total liabilities worth CN¥865.30 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Inner Mongolia Furui Med Sci - Total Liabilities Trend (2006–2024)
This chart illustrates how Inner Mongolia Furui Med Sci's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Inner Mongolia Furui Med Sci Competitors by Total Liabilities
The table below lists competitors of Inner Mongolia Furui Med Sci ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Buckle Inc
NYSE:BKE
|
USA | $566.64 Million |
|
Teekay Tankers Ltd
NYSE:TNK
|
USA | $181.93 Million |
|
Longshine Technology Co Ltd
SHE:300682
|
China | CN¥2.29 Billion |
|
Terravest Capital Inc
TO:TVK
|
Canada | CA$1.36 Billion |
|
Athabasca Oil Corp
PINK:ATHOF
|
USA | $635.31 Million |
|
Zhefu Holding Group Co Ltd
SHE:002266
|
China | CN¥14.78 Billion |
|
Piramal Enterprises Limited
NSE:PEL
|
India | ₹-270.96 Billion |
|
K+S Aktiengesellschaft
F:SDF1
|
Germany | €2.86 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Inner Mongolia Furui Med Sci's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inner Mongolia Furui Med Sci's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inner Mongolia Furui Med Sci (2006–2024)
The table below shows the annual total liabilities of Inner Mongolia Furui Med Sci from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥930.99 Million | +16.36% |
| 2023-12-31 | CN¥800.09 Million | +14.80% |
| 2022-12-31 | CN¥696.94 Million | -3.06% |
| 2021-12-31 | CN¥718.97 Million | +6.51% |
| 2020-12-31 | CN¥675.02 Million | -3.38% |
| 2019-12-31 | CN¥698.66 Million | +12.33% |
| 2018-12-31 | CN¥621.95 Million | +8.93% |
| 2017-12-31 | CN¥570.98 Million | -1.75% |
| 2016-12-31 | CN¥581.15 Million | +48.87% |
| 2015-12-31 | CN¥390.37 Million | -6.18% |
| 2014-12-31 | CN¥416.10 Million | +5.81% |
| 2013-12-31 | CN¥393.25 Million | +102.76% |
| 2012-12-31 | CN¥193.94 Million | +13.84% |
| 2011-12-31 | CN¥170.37 Million | +57.40% |
| 2010-12-31 | CN¥108.24 Million | +15.76% |
| 2009-12-31 | CN¥93.51 Million | +11.88% |
| 2008-12-31 | CN¥83.58 Million | +14.23% |
| 2007-12-31 | CN¥73.17 Million | +15.60% |
| 2006-12-31 | CN¥63.29 Million | -- |